These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9590099)

  • 21. Overview of immunodeficiency diseases where bone marrow transplantation is feasible.
    Nelson DL; Notarangelo LD
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():132. PubMed ID: 2516752
    [No Abstract]   [Full Text] [Related]  

  • 22. [Myoadenylate deaminase deficiency].
    Takeda M; Wada Y
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):451-3. PubMed ID: 9590098
    [No Abstract]   [Full Text] [Related]  

  • 23. [Genetic analysis of two patients with adenosine deaminase (ADA)-deficiency: detection of three novel mutations and characterization of two paradoxical carriers].
    Oda N; Ariga T; Ono S; Kobayashi I; Kawamura N; Okano M; Kobayashi Y; Taniuchi S; Terada K; Kataoka N; Sakiyama Y
    Arerugi; 2000 Dec; 49(12):1173-80. PubMed ID: 11197883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombination.
    Gangi-Peterson L; Sorscher DH; Reynolds JW; Kepler TB; Mitchell BS
    J Clin Invest; 1999 Mar; 103(6):833-41. PubMed ID: 10079104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disorders of purine metabolism: the immune connection.
    Med Times; 1980 Jan; 108(1):12s-14s, 19s-22s. PubMed ID: 6768953
    [No Abstract]   [Full Text] [Related]  

  • 26. Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency.
    Rogers MH; Lwin R; Fairbanks L; Gerritsen B; Gaspar HB
    J Pediatr; 2001 Jul; 139(1):44-50. PubMed ID: 11445793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function of murine adenosine deaminase in the gastrointestinal tract.
    Xu PA; Kellems RE
    Biochem Biophys Res Commun; 2000 Mar; 269(3):749-57. PubMed ID: 10720488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PRPP synthetase deficiency].
    Imaeda H; Wada Y
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):435-7. PubMed ID: 9590093
    [No Abstract]   [Full Text] [Related]  

  • 29. The importance of adenosine deaminase for lymphocyte development and function.
    Aldrich MB; Blackburn MR; Kellems RE
    Biochem Biophys Res Commun; 2000 Jun; 272(2):311-5. PubMed ID: 10833410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adenosine deaminase deficiency].
    Okawa H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):240-2. PubMed ID: 9833480
    [No Abstract]   [Full Text] [Related]  

  • 31. polyethylene glycol-conjugated adenosine deaminase (ADA) therapy provides temporary immune reconstitution to a child with delayed-onset ADA deficiency.
    Lainka E; Hershfield MS; Santisteban I; Bali P; Seibt A; Neubert J; Friedrich W; Niehues T
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):861-6. PubMed ID: 16002636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [PRPP synthetase deficiency].
    Kawasugi K; Takeuchi F
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():383-5. PubMed ID: 12629752
    [No Abstract]   [Full Text] [Related]  

  • 33. New models for the study of adenosine deaminase deficiency.
    Thompson LF
    Adv Exp Med Biol; 1998; 431():447-9. PubMed ID: 9598108
    [No Abstract]   [Full Text] [Related]  

  • 34. Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial.
    Muul LM; Tuschong LM; Soenen SL; Jagadeesh GJ; Ramsey WJ; Long Z; Carter CS; Garabedian EK; Alleyne M; Brown M; Bernstein W; Schurman SH; Fleisher TA; Leitman SF; Dunbar CE; Blaese RM; Candotti F
    Blood; 2003 Apr; 101(7):2563-9. PubMed ID: 12456496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
    Taupin P
    IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary disorders of erythrocyte enzymes in non-glycolytic metabolic pathways.
    Paglia DE; Valentine WN
    Haematologia (Budap); 1982 Dec; 15(4):381-8. PubMed ID: 7186478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An unconditioned bone marrow transplantation in a child with purine nucleoside phosphorylase deficiency and its unique complication.
    Aytekin C; Yuksek M; Dogu F; Yagmurlu A; Yildiran A; Fitoz S; Kologlu M; Babacan E; Hershfield MS; Ikinciogullari A
    Pediatr Transplant; 2008 Jun; 12(4):479-82. PubMed ID: 18208442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of genetic diseases by allotransplantation.
    Hirschhorn R
    Birth Defects Orig Artic Ser; 1980; 16(1):429-44. PubMed ID: 6778530
    [No Abstract]   [Full Text] [Related]  

  • 39. Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry.
    Sanchez JJ; Monaghan G; Børsting C; Norbury G; Morling N; Gaspar HB
    Ann Hum Genet; 2007 May; 71(Pt 3):336-47. PubMed ID: 17181544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seven novel mutations in the adenosine deaminase (ADA) gene in patients with severe and delayed onset combined immunodeficiency: G74C, V129M, G140E, R149W, Q199P, 462delG, and E337del. Mutations in brief no. 142. Online.
    Arrendondo-Vega FX; Santisteban I; Notarangelo LD; El Dahr J; Buckley R; Roifman C; Conley ME; Hershfield MS
    Hum Mutat; 1998; 11(6):482. PubMed ID: 10200056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.